| Class Number |
Class Name |
No. of Patents |
| 514/810 |
Addiction |
99 |
| 514/811 |
Alcohol |
150 |
| 514/812 |
Narcotic |
150 |
| 514/813 |
Tobacco |
131 |
| 514/805 |
Adrenocorticotropic hormone or derivatives |
32 |
| 514/814 |
Anemia |
106 |
| 514/815 |
Sickle cell |
44 |
| 514/816 |
Anesthetic, general |
92 |
| 514/818 |
Anesthetic, local |
106 |
| 514/817 |
Anesthetic, topical |
138 |
| 514/819 |
Antacid, oral |
84 |
| 514/820 |
With antiflatulent |
21 |
| 514/821 |
Antiarrhythmic |
421 |
| 514/822 |
Anticoagulation |
469 |
| 514/823 |
Antidote |
84 |
| 514/824 |
Arteriosclerosis |
607 |
| 514/825 |
Arthritis |
673 |
| 514/826 |
Asthma |
800 |
| 514/827 |
Astringent, nonfacial |
24 |
| 514/828 |
Topical for the skin |
70 |
| 514/829 |
Bite or sting |
41 |
| 514/831 |
Animal (nonpoisonous) |
7 |
| 514/830 |
Insect |
39 |
| 514/833 |
Blood plasma extender |
87 |
| 514/832 |
Blood substitute |
172 |
| 514/959 |
Breathing gases |
47 |
| 514/808 |
Calcitonin or derivatives |
61 |
| 514/962 |
Capsule (e.g., gelatin, etc.) |
306 |
| 514/963 |
Microcapsule-sustained or differential release |
316 |
| 514/835 |
Caries |
94 |
| 514/975 |
Characterized by the designated surfactant used |
357 |
| 514/836 |
Chelate |
221 |
| 514/837 |
Cholera |
18 |
| 514/838 |
Cirrhosis |
33 |
| 514/834 |
Coagulant |
73 |
| 514/801 |
Collagen, gelatin or derivatives thereof |
194 |
| 514/839 |
Contact lens treatment |
114 |
| 514/840 |
Chemical sterilizing |
114 |
| 514/974 |
Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.) |
253 |
| 514/970 |
Containing designated ingredient to stabilize an active ingredient |
486 |
| 514/971 |
Crystallization point depressant or cold stabilizer containing |
47 |
| 514/973 |
Sulfur compound additive as stabilizer (e.g., sulfites, etc.) |
70 |
| 514/972 |
Ultraviolet light stabilizer containing |
92 |
| 514/841 |
Contraceptive |
136 |
| 514/843 |
Female (mammal) |
230 |
| 514/842 |
Non-mammal |
17 |
| 514/844 |
Cosmetic, facial |
1363 |
| 514/846 |
Cleansing cream or lotion |
598 |
| 514/848 |
Facial astringent |
122 |
| 514/847 |
Facial moisturizer |
693 |
| 514/845 |
Liquid make-up |
284 |
| 514/849 |
Cough and cold preparation |
119 |
| 514/850 |
Antitussive |
44 |
| 514/851 |
Cystic fibrosis |
110 |
| 514/852 |
Dandruff |
113 |
| 514/853 |
Decongestant |
62 |
| 514/855 |
Expectorant |
38 |
| 514/854 |
Vasoconstrictor |
18 |
| | Dermatitis | |
| 514/859 |
Acne |
552 |
| 514/858 |
Athlete's foot |
77 |
| 514/860 |
Cellulitis |
62 |
| 514/865 |
Diaper rash |
80 |
| 514/861 |
Eczema |
276 |
| 514/862 |
Poison (ivy, oak, sumac) |
78 |
| 514/863 |
Psoriasis |
541 |
| 514/864 |
Seborrhea |
209 |
| 514/769 |
Designated inorganic nonactive ingredient or elemental material other than water |
146 |
| 514/771 |
Oxygen gas containing |
22 |
| 514/770 |
Siliceous or calcareous material (e.g., clay, earth, etc.) |
305 |
| 514/1 |
Designated organic active ingredient containing (doai) |
323 |
| | Designated organic active ingredient containing (doai) | |
| 514/152 |
3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai |
251 |
| 514/154 |
With an additional active ingredient (excludes reaction product or complex) |
64 |
| 514/153 |
With stabilizer or preservative |
28 |
| 514/167 |
9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai |
543 |
| 514/168 |
With a vitamin type active ingredient |
154 |
| 514/150 |
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai |
243 |
| 514/151 |
Acyclic c-n=n-n containing |
97 |
| 514/693 |
Aldehyde doai |
152 |
| 514/699 |
Benzene ring containing |
85 |
| 514/701 |
Acyclic carbon to carbon unsaturation |
33 |
| 514/700 |
Polycyclo ring system |
37 |
| 514/703 |
Carbon to carbon unsaturation |
101 |
| 514/694 |
Formaldehyde |
45 |
| 514/696 |
With alcohol |
18 |
| 514/697 |
With nitrogen containing compound |
10 |
| 514/695 |
With polycyclo compound |
4 |
| 514/704 |
Nitrogen containing |
13 |
| 514/705 |
Plural c=o groups |
81 |
| 514/702 |
Sulfur containing |
23 |
| 514/698 |
With preservative or stabilizer |
37 |
| 514/149 |
Azoxy doai |
40 |
| 514/64 |
Boron containing doai |
183 |
| 514/724 |
C-o-group (e.g., alcohol, alcoholate, etc.) doai |
467 |
| 514/729 |
Alicyclic ring containing |
268 |
| 514/730 |
Benzene ring containing |
187 |
| 514/731 |
C of c-o- group is nuclear c of a benzene ring (e.g., phenol, phenolate, etc.) |
308 |
| 514/733 |
Acyclic carbon to carbon unsaturation |
97 |
| 514/736 |
Additional benzene ring containing |
88 |
| 514/737 |
Nuclear halogenated |
61 |
| 514/732 |
Polycyclo ring system (e.g., naphthols, etc.) |
127 |
| 514/734 |
Two or more separate aryl-o-groups |
93 |
| 514/735 |
Nuclear halogenated |
30 |
| 514/739 |
Carbon to carbon unsaturated |
201 |
| 514/726 |
Diphenyl-substituted acyclic alcohol or alcoholate |
44 |
| 514/727 |
Nitrogen containing |
113 |
| 514/728 |
C of c-o- group is nuclear c of a benzene ring (e.g., phenol, phenolate, etc.) |
68 |
| 514/738 |
Polyhydroxy |
276 |
| 514/725 |
Vitamin a compound or derivative |
493 |
| 514/23 |
Carbohydrate (i.e., saccharide radical containing) doai |
1350 |
| 514/53 |
Dissacharide |
641 |
| 514/62 |
Glucosamine or derivative |
355 |
| 514/42 |
N-glycoside |
279 |
| 514/43 |
Nitrogen containing hetero ring |
369 |
| 514/52 |
Phosphorus containing (e.g., vitamin b12, etc.) |
244 |
| 514/44 |
Polynucleotide (e.g., rna, dna, etc.) |
3040 |
| 514/45 |
Purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
491 |
| 514/46 |
Adenosine or derivative |
590 |
| 514/47 |
Phosphorus containing |
353 |
| 514/48 |
Phosphorus containing |
202 |
| 514/49 |
Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
468 |
| 514/50 |
2,4-diketone pyrimidine or derivative (e.g., uracil, etc.) |
482 |
| 514/51 |
Phosphorus containing |
241 |
| 514/25 |
O-glycoside |
1130 |
| 514/26 |
Cyclopentanohydrophenanthrene ring system |
257 |
| 514/35 |
Oxygen of the saccharide radical bonded directly to a cyclohexyl ring |
106 |
| 514/36 |
Two or more nitrogen atoms bonded directly to the cyclohexyl ring |
78 |
| 514/37 |
The nitrogen atoms are in n-c(=n)-n groups (e.g., streptomycin, etc.) |
82 |
| 514/40 |
Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring |
98 |
| 514/41 |
Kanamycin or derivative |
73 |
| 514/38 |
Two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl ring |
42 |
| 514/39 |
Three or more saccharide radicals (e.g., neomycin, etc.) |
110 |
| 514/27 |
Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring |
376 |
| 514/28 |
The hetero ring has 8 or more ring carbons |
125 |
| 514/31 |
The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.) |
166 |
| 514/29 |
The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.) |
435 |
| 514/30 |
The hetero ring has exactly 15 ring carbons |
264 |
| 514/33 |
Oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings |
137 |
| 514/34 |
Oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.) |
336 |
| 514/32 |
Oxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bonding |
68 |
| 514/54 |
Polysaccharide |
1893 |
| 514/57 |
Cellulose or derivative |
319 |
| 514/55 |
Chitin or derivative |
262 |
| 514/59 |
Dextran or derivative |
259 |
| 514/58 |
Dextrin or derivative |
495 |
| 514/56 |
Heparin or derivative |
447 |
| 514/60 |
Starch or derivative |
265 |
| 514/61 |
Tri- or tetrasaccharide |
227 |
| 514/24 |
S-glycoside |
212 |
| 514/169 |
Cyclopentanohydrophenanthrene ring system doai |
451 |
| 514/172 |
Hetero ring containing |
236 |
| 514/175 |
-c(=o)-o-is part of a hetero ring (e.g., lactone, etc.) |
87 |
| 514/174 |
-o-c-o- is part of a hetero ring (e.g., acetonide, etc.) |
162 |
| 514/176 |
Nitrogen containing hetero ring |
246 |
| 514/173 |
Spiro ring system |
99 |
| 514/177 |
Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system |
487 |
| 514/178 |
Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system |
655 |
| 514/181 |
21-position substituted |
143 |
| 514/179 |
Modified c-ring (except methyl in 13-position) (e.g., double bond containing, substituted, etc.) |
611 |
| 514/180 |
9-position substituted |
274 |
| 514/182 |
Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system |
883 |
| 514/170 |
Plural compounds containing cyclopentanohydrophenanthrene ring systems |
315 |
| 514/171 |
With additional active ingredient |
570 |
| 514/506 |
Ester doai |
218 |
| 514/509 |
(o=)n(=o)-o-c containing (e.g., nitrate ester, etc.) |
91 |
| 514/513 |
C-c(=x)-x-c containing (x is chalcogen and at least one x is other than oxygen) |
251 |
| 514/514 |
Carbon bonded to -ncx or -xcn (e.g., cyanate, thiocyanate or isothiocyanate, etc.) (x is chalcogen) |
121 |
| 514/516 |
Containing plural -ncx or -xcn groups or a cyano |
35 |
| 514/515 |
With an additional active ingredient |
54 |
| 514/519 |
Cyano or isocyano bonded directly to carbon |
119 |
| 514/526 |
Acyclic |
65 |
| 514/527 |
C=o other than as ketone or aldehyde |
36 |
| 514/528 |
C(=o)n containing |
82 |
| 514/520 |
Benzene ring containing |
271 |
| 514/523 |
Additional nitrogen other than cyano |
201 |
| 514/524 |
The cyano is bonded directly to a benzene ring |
206 |
| 514/521 |
C=o other than as ketone or aldehyde |
521 |
| 514/522 |
The cyano is bonded directly to a benzene ring |
391 |
| 514/525 |
Two or more of the cyano groups |
100 |
| 514/510 |
Polycyclo ring system |
426 |
| 514/511 |
Two of the cyclos share at least three ring members (i.e., bridged) |
56 |
| 514/507 |
R-c(=x)-n-x-c containing (e.g., hydroxamic acid ester, etc.) (r is c or h and x is chalcogen) |
74 |
| 514/517 |
S-x-c containing (e.g., sulfates, etc.) (x is chalcogen) |
231 |
| 514/518 |
S of s-x-c attached directly to a benzene ring |
95 |
| 514/512 |
X-c(=x)-x containing (e.g., carbonic acid ester, thiocarbonic acid ester, etc.) (x is chalcogen) |
168 |
| 514/508 |
X-c=n containing (e.g., imidoester, etc.) (x is chalcogen) |
77 |
| 514/529 |
Z-c(=o)-o-y wherein z is hydrogen or an organic radical bonded to the c(=o) by a carbon and y is an organic radical bonded to the oxygen by a carbon |
356 |
| 514/530 |
Z contains a cyclopentyl or cyclopentene ring |
627 |
| 514/531 |
Z contains a cyclopropyl or cyclopropene ring |
517 |
| 514/532 |
Z-c(=o)-o-y, wherein z contains a benzene ring |
502 |
| 514/544 |
C(=o)o attached directly through the carbon to a benzene ring |
300 |
| 514/533 |
Compound contains two or more c(=o)o groups indirectly bonded together by only conalent bonds |
521 |
| 514/545 |
Ketone in z radical |
99 |
| 514/543 |
Z forms a phenoxy alkyl or phenoxy alkenyl radical |
165 |
| 514/534 |
Z or y radical contains a nitrogen atom |
379 |
| 514/538 |
Nitrogen bonded to carbon in z moiety |
524 |
| 514/541 |
Aldehyde or ketone in z or y radical |
84 |
| 514/540 |
Nitrogen in y moiety |
103 |
| 514/539 |
Plural separated benzene rings in z moiety |
483 |
| 514/542 |
Z radical contains two or more nitrogen atoms at least one of which forms a c(=x)n group (x is chalcogen) |
160 |
| 514/535 |
The nitrogen of the z radical is directly bonded to a benzene ring which is directly bonded to the c(=o) group |
385 |
| 514/537 |
With an additional active ingredient |
73 |
| 514/536 |
With an agent to enhance topical absorption or with a stabilizing agent |
46 |
| 514/546 |
Zc(=o)oy, wherein z is an acyclic radical bonded to the c=o by a carbon and y is an organic radical bonded to the oxygen by a carbon |
668 |
| 514/547 |
Compound contains two or more c(=o)o groups |
567 |
| 514/548 |
Ring is alcohol moiety |
282 |
| 514/552 |
Z contains an unbroken chain of at least seven carbon atoms bonded directly to the c(=o) group |
359 |
| 514/549 |
Z radical contains carbon to carbon unsaturation |
409 |
| 514/551 |
Z radical contains nitrogen |
189 |
| 514/550 |
Z radical contains sulfur or halogen |
155 |
| 514/715 |
Ether doai |
109 |
| 514/722 |
Acyclic |
96 |
| 514/723 |
Plural oxygens |
193 |
| 514/717 |
Benzene ring containing |
217 |
| 514/718 |
Plural oxygens |
183 |
| 514/720 |
Acyclic carbon to carbon unsaturation |
117 |
| 514/719 |
Alicyclic ring |
78 |
| 514/721 |
Plural benzene rings |
191 |
| 514/716 |
Nitrogen containing |
100 |
| 514/743 |
Halogenated hydrocarbon doai |
64 |
| 514/760 |
Bromine and chlorine as only halogens |
6 |
| 514/761 |
Bromine and fluorine as only halogens |
14 |
| 514/747 |
Carbocyclic |
41 |
| 514/751 |
Benzene ring containing |
29 |
| 514/752 |
Alkyne |
12 |
| 514/754 |
Plural benzene rings |
26 |
| 514/753 |
Polycyclo ring system |
15 |
| 514/755 |
Polycyclo ring system |
29 |
| 514/756 |
Bicyclo |
34 |
| 514/748 |
Two benzene rings directly attached to an acyclic hydrocarbon or acyclic halogenated hydrocarbon (e.g., d.d.t., etc.) |
22 |
| 514/749 |
Fluorine containing |
26 |
| 514/750 |
With organic ether or -oh containing compound non-doai |
5 |
| 514/758 |
Chlorine as only halogen |
22 |
| 514/759 |
Fluorine as only halogen |
72 |
| 514/757 |
Two or more halogenated hydrocarbons |
34 |
| 514/744 |
Unsaturated aliphatic compound |
41 |
| 514/745 |
Alkyne |
11 |
| 514/746 |
Plural halogenated hydrocarbon compounds |
37 |
| 514/492 |
Heavy metal containing doai |
551 |
| 514/503 |
Antimony or bismuth |
60 |
| 514/504 |
Arsenic |
39 |
| 514/505 |
Cadmium or chromium |
94 |
| 514/499 |
Copper |
245 |
| 514/500 |
With an additional active ingredient |
130 |
| 514/495 |
Gold or silver |
98 |
| 514/502 |
Iron |
244 |
| 514/498 |
Lead |
20 |
| 514/496 |
Mercury |
40 |
| 514/497 |
Nitrogen containing |
16 |
| 514/501 |
Nickel or cobalt |
116 |
| 514/493 |
Tin |
167 |
| 514/494 |
Zinc |
315 |
| 514/183 |
Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai |
1461 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
267 |
| 514/195 |
3-position substituent contains -cooc- group |
162 |
| 514/194 |
6,6-di-substituted |
55 |
| 514/197 |
6-position substituent contains carbocyclic ring |
108 |
| 514/198 |
Ampicillin per se or salt thereof |
79 |
| 514/199 |
Penicillin g per se or salt thereof (e.g., procaine pencillin g, etc.) |
88 |
| 514/196 |
6-position substituent contains hetero ring |
126 |
| 514/193 |
Spiro or additional polycyclo ring system |
78 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
177 |
| 514/201 |
7,7-di-substituted |
163 |
| 514/202 |
Additional hetero ring |
353 |
| 514/203 |
3-position substituent contains pyridine ring |
181 |
| 514/204 |
3-position substituent contains sulfur |
154 |
| 514/206 |
7-position substituent contains hetero ring |
377 |
| 514/205 |
The additional hetero ring is part of a polycyclo ring system |
72 |
| 514/207 |
Alkyl, hydroxyalkyl, alkoxyalkyl or alkanoyloxyakyl bonded directly to 3-position |
140 |
| 514/209 |
Alkyl, hydroxyalkyl, alkoxyalkyl, or alkanoyloxyakyl bonded directly to 3-position |
70 |
| 514/208 |
Sulfur containing substituent |
58 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
557 |
| 514/383 |
1,2,4-triazoles (including hydrogenated) |
1380 |
| 514/384 |
Chalcogen bonded directly to the triazole ring |
314 |
| 514/403 |
1,2-diazoles |
456 |
| 514/404 |
Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent |
282 |
| 514/405 |
Polycyclo ring system having the diazole ring as one of the cyclos |
123 |
| 514/406 |
Pyrazoles |
876 |
| 514/407 |
Chalcogen or nitrogen bonded directly to the pyrazole ring by nonionic bonding |
529 |
| 514/378 |
1,2-oxazoles (including hydrogenated) |
717 |
| 514/380 |
Chalcogen or nitrogen bonded directly to ring carbon of the oxazole ring |
318 |
| 514/379 |
Polycyclo ring system having the oxazole ring as one of the cyclos |
218 |
| 514/372 |
1,2-thiazoles (including hydrogenated) |
683 |
| 514/373 |
Polycyclo ring system having the thiazole ring as one of the cyclos |
340 |
| 514/385 |
1,3-diazoles |
307 |
| 514/401 |
2-imidazolines |
242 |
| 514/402 |
Additional hetero ring |
138 |
| 514/386 |
Divalent chalcogen or acyclic nitrogen double bonded directly to ring carbon of the diazole ring, or tautomeric equivalent |
147 |
| 514/392 |
Divalent chalcogen or acyclic nitrogen double bonded at 2-position, or tautomeric equivalent |
327 |
| 514/389 |
Divalent chalcogen or acyclic nitrogen double bonded directly at both 2- and 4- positions, or tautomeric equivalent (e.g., hydantoin, etc.) |
254 |
| 514/391 |
Benzene ring bonded directly to the diazole ring by nonionic bonding |
110 |
| 514/390 |
Chalcogen or nitrogen bonded directly at 1-, 3-, or 5-position by nonionic bonding |
112 |
| 514/387 |
Polycyclo ring system having the diazole ring as one of the cyclos |
260 |
| 514/388 |
Nitrogen double bonded directly at 2-position of the diazole ring, or tautomeric equivalent |
179 |
| 514/396 |
Imidazoles |
620 |
| 514/397 |
Additional hetero ring |
1349 |
| 514/398 |
Chalcogen or nitrogen bonded directly to the imidazole ring by nonionic bonding |
605 |
| 514/399 |
Chalcogen or nitrogen bonded indirectly to the imidazole ring by nonionic bonding |
960 |
| 514/400 |
At imidazole ring carbon |
776 |
| 514/393 |
Polycyclo ring system having the diazole ring as one of the cyclos |
230 |
| 514/394 |
Benzo fused at 4,5-positions of the diazole ring |
702 |
| 514/395 |
Chalcogen or nitrogen bonded directly at 1-, 2- or 3-position of the diazole ring by nonionic bonding |
354 |
| 514/374 |
1,3-oxazoles (including hydrogenated) |
1048 |
| 514/376 |
Chalcogen bonded directly to ring carbon of the oxazole ring |
566 |
| 514/377 |
Nitrogen bonded directly to ring carbon of the oxazole ring |
227 |
| 514/375 |
Polycyclo ring system having the oxazole ring as one of the cyclos |
518 |
| 514/365 |
1,3-thiazoles (including hydrogenated) |
1658 |
| 514/369 |
Chalcogen bonded directly to ring carbon of the thiazole ring |
786 |
| 514/370 |
Nitrogen bonded directly to ring carbon of the thiazole ring |
505 |
| 514/371 |
C=x bonded directly to the nitrogen which is bonded directly to the thiazole ring (x is chalcogen) |
218 |
| 514/366 |
Polycyclo ring system having the thiazole ring as one of the cyclos |
155 |
| 514/367 |
Bicyclo ring system having the thiazole ring as one of the cyclos |
711 |
| 514/368 |
Ring nitrogen is shared by the cyclos of the bicyclo ring system (e.g., tetramisole, etc.) |
138 |
| 514/360 |
Plural ring chalcogens in the hetero ring |
127 |
| 514/361 |
Plural ring nitrogens and a single chalcogen in the hetero ring |
376 |
| 514/362 |
1,2,5-thiadiazoles (including hydrogenated) |
319 |
| 514/363 |
1,3,4-thiadiazoles (including hydrogenated) |
453 |
| 514/364 |
Oxadiazoles (including hydrogenated) |
604 |
| 514/381 |
Tetrazoles (including hydrogenated) |
889 |
| 514/382 |
Additional chalcogen containing hetero ring |
321 |
| 514/408 |
The five-membered hetero ring consists of one nitrogen and four carbons |
539 |
| 514/422 |
Additional hetero ring |
1587 |
| 514/423 |
C=x bonded directly to the five-membered hetero ring by nonionic bonding (x is chalcogen) |
1223 |
| 514/429 |
Carbocyclic ring bonded directly to the five-membered hetero ring |
211 |
| 514/424 |
Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding |
596 |
| 514/425 |
Plural chalcogens bonded directly to the five-membered hetero ring by nonionic bonding |
284 |
| 514/428 |
Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding |
793 |
| 514/426 |
Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding |
242 |
| 514/410 |
Polycyclo ring system having the five-membered hetero ring as one of the cyclos |
551 |
| 514/412 |
Bicyclo ring system having the five-membered hetero ring as one of the cyclos |
338 |
| 514/414 |
Additional hetero ring which is not part of the bicyclo ring system |
852 |
| 514/421 |
Chalcogen bonded directly to ring carbon of the five-membered hetero ring (e.g., adrenochrome, etc.) |
152 |
| 514/413 |
Ring nitrogen is shared by the cyclos of the bicyclo ring system |
183 |
| 514/415 |
The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.) |
1027 |
| 514/419 |
C=x bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (x is chalcogen) |
796 |
| 514/420 |
Indomethacine per se or ester thereof |
179 |
| 514/418 |
Chalcogen bonded directly to ring carbon of the five-membered hetero ring |
390 |
| 514/416 |
The ring nitrogen is bonded directly to nonshared ring carbons of the five-membered hetero ring (e.g., isoindole, etc.) |
244 |
| 514/417 |
Plural chalcogens bonded directly to ring carbons of the five-membered hetero ring (e.g., phthalimide, etc.) |
209 |
| 514/411 |
Tricyclo ring system having the five-membered hetero ring as one of the cyclos |
724 |
| 514/409 |
Spiro ring system |
267 |
| 514/427 |
Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.) |
466 |
| 514/184 |
Heavy metal containing (including salts) |
543 |
| 514/188 |
Hetero ring is six-membered consisting of one nitrogen and five carbons |
241 |
| 514/190 |
Mercury |
19 |
| 514/185 |
Polycyclo ring system |
360 |
| 514/186 |
Bicyclo ring system |
132 |
| 514/187 |
Quinolines or isoquinolines (including hydrogenated) |
79 |
| 514/189 |
Tin |
69 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
165 |
| 514/211.15 |
Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding |
280 |
| 514/211.03 |
Chalcogen double bonded directly to a ring carbon which is adjacent to the ring nitrogen |
66 |
| 514/211.04 |
Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos |
52 |
| 514/211.05 |
Bicyclo ring system having the seven-membered hetero ring as one of the cyclos |
67 |
| 514/211.06 |
Ring chalcogen and ring nitrogen are in the 1,5-positions of the seven-membered hetero ring |
37 |
| 514/211.07 |
Nitrogen attached directly or indirectly to the ring nitrogen of the seven-membered hetero ring by acyclic nonionic bonding (e.g., diltiazem, etc.) |
106 |
| 514/211.02 |
|